256 related articles for article (PubMed ID: 18462303)
1. Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis.
Karlsmark T; Goodman JJ; Drouault Y; Lufrano L; Pledger GW;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1184-92. PubMed ID: 18462303
[TBL] [Abstract][Full Text] [Related]
2. Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.
Morrel EM; Spruance SL; Goldberg DI;
Clin Infect Dis; 2006 Aug; 43(4):460-7. PubMed ID: 16838235
[TBL] [Abstract][Full Text] [Related]
3. Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial.
Zschocke I; Reich C; Zielke A; Reitmeier N; Reich K
J Dermatolog Treat; 2008; 19(3):176-81. PubMed ID: 18569274
[TBL] [Abstract][Full Text] [Related]
4. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
[TBL] [Abstract][Full Text] [Related]
5. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of combination acyclovir 5% and hydrocortisone 1% cream in adolescents with recurrent herpes simplex labialis.
Strand A; Böttiger D; Gever LN; Wheeler W
Pediatr Dermatol; 2012; 29(1):105-10. PubMed ID: 22004219
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
[TBL] [Abstract][Full Text] [Related]
8. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
Hull CM; Brunton S
Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
[TBL] [Abstract][Full Text] [Related]
9. Clinical Study on the Effectiveness of Three Products in the Treatment of Herpes Simplex Labialis.
Boes H; Goulioumis V; Wechsler A; Zimmer S; Bizhang M
Sci Rep; 2020 Apr; 10(1):6465. PubMed ID: 32296094
[TBL] [Abstract][Full Text] [Related]
10. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
[TBL] [Abstract][Full Text] [Related]
11. Recurrent herpes labialis: efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir).
Femiano F; Gombos F; Scully C
Oral Dis; 2001 Jan; 7(1):31-3. PubMed ID: 11354919
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials.
Raborn GW; Martel AY; Lassonde M; Lewis MA; Boon R; Spruance SL;
J Am Dent Assoc; 2002 Mar; 133(3):303-9. PubMed ID: 11934185
[TBL] [Abstract][Full Text] [Related]
13. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group.
Boon R; Goodman JJ; Martinez J; Marks GL; Gamble M; Welch C
Clin Ther; 2000 Jan; 22(1):76-90. PubMed ID: 10688392
[TBL] [Abstract][Full Text] [Related]
14. Topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions.
Al-Waili NS
Med Sci Monit; 2004 Aug; 10(8):MT94-8. PubMed ID: 15278008
[TBL] [Abstract][Full Text] [Related]
15. Docosanol: new drug. Herpes labialis: barely more effective than an excipient.
Prescrire Int; 2009 Jun; 18(101):106-7. PubMed ID: 19637417
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the efficacy and safety of a CS20® protective barrier gel containing OGT compared with topical aciclovir and placebo on functional and objective symptoms of labial herpes recurrences: a randomized clinical trial.
Khemis A; Duteil L; Coudert AC; Tillet Y; Dereure O; Ortonne JP
J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1240-6. PubMed ID: 21981375
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of herpes simplex virus isolates to nucleoside analogues and the proportion of nucleoside-resistant variants after repeated topical application of penciclovir to recurrent herpes labialis.
Shin YK; Weinberg A; Spruance S; Bernard M; Bacon TH; Boon RJ; Levin MJ
J Infect Dis; 2003 Apr; 187(8):1241-5. PubMed ID: 12696003
[TBL] [Abstract][Full Text] [Related]
18. Comment to: topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions Al-Waili NS Med Sci Monit, 2004; 10(8): MT94-MT98.
Carilli S
Med Sci Monit; 2005 Dec; 11(12):LE24. PubMed ID: 16319801
[No Abstract] [Full Text] [Related]
19. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
Nguyen HP; Stiegel KR; Downing C; Stiegel KR
Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
[TBL] [Abstract][Full Text] [Related]
20. Treatment of herpes labialis with acyclovir. Review of three clinical trials.
Raborn GW; McGaw WT; Grace M; Percy J
Am J Med; 1988 Aug; 85(2A):39-42. PubMed ID: 3044091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
